Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
acetylcholinesterase | 2 | 0 | 0 | 2 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
pregnane X receptor | 2 | 0 | 0 | 2 |
phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
RAR-related orphan receptor gamma | 2 | 0 | 0 | 2 |
USP1 protein, partial | 2 | 0 | 0 | 2 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
Thrombopoietin | 2 | 0 | 0 | 2 |
AR protein | 4 | 0 | 0 | 4 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
glucocorticoid receptor [Homo sapiens] | 4 | 0 | 0 | 4 |
retinoic acid nuclear receptor alpha variant 1 | 4 | 0 | 0 | 4 |
retinoid X nuclear receptor alpha | 1 | 0 | 0 | 1 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
estrogen nuclear receptor alpha | 5 | 0 | 0 | 5 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 3 | 0 | 0 | 3 |
arylsulfatase A | 2 | 0 | 0 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | 5 | 0 | 0 | 5 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 3 | 0 | 0 | 3 |
heat shock protein beta-1 | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 2 | 0 | 0 | 2 |
geminin | 3 | 0 | 0 | 3 |
peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
Histone deacetylase 3 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Histone deacetylase 1 | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 1 | 0 | 1 |
Histone deacetylase 2 | 0 | 1 | 0 | 1 |
Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
Histone deacetylase 11 | 0 | 1 | 0 | 1 |
Ataxin-2 | 1 | 0 | 0 | 1 |
Histone deacetylase 8 | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
Histone deacetylase 9 | 0 | 1 | 0 | 1 |
Histone deacetylase 5 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
GLI family zinc finger 3 | 2 | 0 | 0 | 2 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 2 | 0 | 0 | 2 |
estrogen-related nuclear receptor alpha | 3 | 0 | 0 | 3 |
IDH1 | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 3 | 0 | 0 | 3 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 0 | 1 |
Urease | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 0 | 1 | 1 |
Spike glycoprotein | 3 | 0 | 0 | 3 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
Egl nine homolog 1 | 0 | 0 | 0 | 1 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Cellular tumor antigen p53 | 3 | 0 | 0 | 3 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 2 | 0 | 2 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 2 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
EWS/FLI fusion protein | 3 | 0 | 0 | 3 |
ATP-binding cassette sub-family C member 3 | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 4 | 0 | 2 | 0 | 2 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Synaptic vesicle glycoprotein 2A | 0 | 2 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 2 |
GLS protein | 3 | 0 | 0 | 3 |
TDP1 protein | 4 | 0 | 0 | 4 |
Albumin | 0 | 0 | 2 | 3 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
Matrilysin | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
thioredoxin reductase | 2 | 0 | 0 | 2 |
ATAD5 protein, partial | 2 | 0 | 0 | 2 |
Hsf1 protein | 0 | 0 | 1 | 2 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
peroxisome proliferator activated receptor gamma | 1 | 0 | 0 | 1 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
progesterone receptor | 1 | 0 | 0 | 1 |
pregnane X nuclear receptor | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
Glucocorticoid receptor | 0 | 2 | 1 | 3 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
Smad3 | 1 | 0 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Interferon beta | 1 | 0 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
DNA topoisomerase 2-alpha | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
Sulfate anion transporter 1 | 0 | 0 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
Retinol-binding protein 4 | 0 | 1 | 0 | 1 |
Transthyretin | 0 | 1 | 1 | 2 |
Cholinesterase | 0 | 1 | 0 | 1 |
Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |